SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-072999
Filing Date
2020-03-13
Accepted
2020-03-13 16:50:08
Documents
4
Effectiveness Date
2020-03-13

Document Format Files

Seq Description Document Type Size
1 S-8 d869306ds8.htm S-8 47366
2 EX-5.1 d869306dex51.htm EX-5.1 8113
3 EX-23.1 d869306dex231.htm EX-23.1 1567
4 GRAPHIC g869306g0312153317401.jpg GRAPHIC 2403
  Complete submission text file 0001193125-20-072999.txt   61586
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-237173 | Film No.: 20713500
SIC: 2836 Biological Products, (No Diagnostic Substances)